Clinical Drug Experience Knowledgebase

Brain Neoplasms (Phase 2)

Breast Neoplasms (Phase 3)

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma, Neuroendocrine (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 4)

Carcinoma, Squamous Cell (Phase 2)

Colonic Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 3)

Digestive System Neoplasms (Phase 1)

Endometrial Neoplasms (Phase 2)

Fallopian Tube Neoplasms (Phase 2)

Gastrointestinal Neoplasms (Phase 1)

Head and Neck Neoplasms (Phase 1)

Hodgkin Disease (Phase 3)

Hypersensitivity (Phase 3)

Leukemia (Phase 2)

Leukemia, Lymphoid (Phase 2)

Lung Neoplasms (Phase 3)

Lymphoma (Phase 3)

Lymphoma, Non-Hodgkin (Phase 1)

Melanoma (Phase 3)

Mesothelioma (Phase 2)

Nausea (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 1)

Neoplasms, Connective and Soft Tissue (Phase 1)

Neoplasms, Second Primary (Phase 2)

Neuralgia (Phase 2)

Neuroendocrine Tumors (Phase 2)

Ovarian Neoplasms (Phase 4)

Pain, Intractable (Phase 2)

Pancreatic Neoplasms (Phase 3)

Pneumonia (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Prostatic Neoplasms (Phase 3)

Rectal Neoplasms (Phase 2)

Recurrence (Phase 3)

Respiratory Tract Neoplasms (Phase 1)

Skin Neoplasms (Phase 1)

Small Cell Lung Carcinoma (Phase 3)

Soft Tissue Neoplasms (Phase 1)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Urogenital Neoplasms (Phase 1)

Uterine Cervical Neoplasms (Phase 3)

Vomiting (Phase 2)